A certificate of analysis is the only document standing between you and a vial of the wrong molecule. Reading one takes three minutes once you know which lines carry signal — and which line vendors are counting on you to stop at.
A COA certifies four things in descending order of importance: identity (is it the claimed molecule), mass confirmation, purity (what fraction of the peptide content is the main peak), and the batch match to the vial in your hand. A high purity number without identity confirmation certifies nothing.
What a COA is — and what it is not
A certificate of analysis is a per-batch laboratory report: the analytical results for one specific production lot, signed against defined test methods. It is not a marketing document, a general product datasheet, or a claim about the batch you receive unless the lot number on the certificate matches the lot number on your vial.
Two different documents circulate under the same name. The manufacturer's COA is issued by the synthesis facility itself — useful, but it grades the facility's own homework. A third-party COA comes from an independent laboratory with no stake in the result. The strongest suppliers publish both, and the third-party document is the one that carries evidentiary weight.
Line one: identity
Purity tells you how much of the sample is one dominant molecule. Identity testing tells you which molecule that is — and it is the line most COAs in this market are missing. Mass spectrometry is the standard method: the measured molecular mass is compared against the theoretical mass of the claimed sequence. A match within instrument tolerance confirms you are looking at the right compound; a miss means the purity number describes the wrong substance very precisely.
For quality-control work, laboratories characterize reference standards by high-resolution mass spectrometry and nuclear magnetic resonance before using them to test production material — the same logic, one level up. A COA that reports an HPLC purity with no mass confirmation anywhere on the page is a red flag dressed as a credential.
The purity number, and how it is produced
Peptide purity is reported from reversed-phase HPLC: the sample is run through a column, the detector traces peaks, and purity is the main peak's share of total peak area. Two things follow from the method. First, purity is relative to what the column separates — impurities that co-elute with the main peak are invisible to it. Second, the number says nothing about how much peptide is in the vial at all: a 99% pure sample can sit in a vial that is half filler by weight, because purity and net peptide content are different measurements.
Regulatory practice treats impurity reporting, identification and qualification as threshold-based — the discipline behind ICH's impurity guidance for new drug substances. A research-market COA is not held to that standard, which is exactly why the buyer has to supply the scrutiny the framework would otherwise impose.
Accreditation: who tested this, and who checked the tester
A laboratory's accreditation is the answer to "why should this report be believed." ISO/IEC 17025 is the international standard for testing-laboratory competence, and accreditation bodies such as A2LA audit laboratories against it — method validation, instrument calibration, proficiency testing, traceability. An accredited lab's scope certificate is public and searchable.
The practical check: the COA names the laboratory, the laboratory is findable, and its accreditation scope covers the analysis performed. A certificate with no laboratory name, or a name that returns nothing, is an assertion — not an analysis.
Research peptides
Batch-documented research-use-only peptides — every lot ships against its certificate of analysis, and the certificate is retrievable by lot number.
The batch match — the step everyone skips
Everything above certifies a lot. The final step certifies your vial: the lot or batch number printed on the certificate must match the one printed on the label in your hand. A supplier reusing one flattering COA across many production runs is the market's oldest trick, and the lot number is how you catch it.
The strongest pattern currently in the market: a QR code or lot lookup on the vial label that resolves to the certificate for that specific batch. If the supplier's site lets you pull the COA by lot number, the batch match takes seconds. If no lot appears anywhere, there is nothing to match — treat the certificate as decoration.
A 60-second COA checklist
- Lot number on the certificate matches the vial label.
- Identity confirmed by mass spectrometry against the theoretical mass.
- Purity reported from HPLC with the chromatogram shown, not just a number.
- Laboratory named, independent of the seller, with verifiable accreditation.
- Test date consistent with the batch's production window.
- Net content stated separately from purity, if the vendor reports it at all.
Any single miss is survivable context. Two or more misses on one certificate is a pattern, and the pattern is the answer.
Research peptides
Third-party tested research compounds, each shipped with a batch-matched certificate of analysis showing HPLC purity and mass-spec identity — the documentation this site argues you should hold any supplier to.
What to know now
- Identity beats purity. Mass-spec confirmation that the molecule is what the label claims matters more than the decimal on the HPLC number.
- Purity is the main peak's share of HPLC peak area — relative to what the column separates, and silent about net peptide content.
- ISO/IEC 17025 accreditation (audited by bodies like A2LA) is what makes a third-party lab's report believable — and scopes are publicly searchable.
- The certificate certifies a lot; the lot-number match to your vial is what makes it certify your purchase.
- One flattering COA reused across many batches is the market's oldest trick. No lot number, no evidence.
What we're watching
Whether research-market suppliers move toward per-lot QR verification as standard practice — and whether any accreditation body begins auditing research-chemical COA claims directly, which would collapse the gap between marketing purity and certified purity overnight.
Frequently asked questions
How do I read a certificate of analysis for peptides?
Check four things in order: the lot number matches your vial, identity is confirmed by mass spectrometry, purity comes from HPLC with the chromatogram shown, and the testing laboratory is named, independent, and accredited. The purity number alone — the line most people read first — certifies the least.
What is the difference between a manufacturer COA and third-party testing?
A manufacturer's COA is issued by the facility that made the peptide; a third-party COA comes from an independent laboratory with no stake in the result. Both have value, but the independent report is the one that functions as evidence rather than self-assessment.
What purity should a research peptide COA show?
Most research suppliers list ≥98–99% HPLC purity. The honest reading: that number is the main peak's share of peak area under one chromatographic method. Identity confirmation and the lot match determine whether it means anything for the vial you received.
Does a COA tell me how much peptide is in the vial?
Usually not. HPLC purity and net peptide content are different measurements — a vial can contain 99%-pure material and still hold less total peptide than the label implies. Suppliers that report net content per vial are answering a question most certificates skip.
References
- Mant, C. T., & Hodges, R. S. (Eds.). (1991). High-Performance Liquid Chromatography of Peptides and Proteins: Separation, Analysis, and Conformation. Boca Raton, FL: CRC Press. https://doi.org/10.1201/9780203751947
- International Organization for Standardization. (2017). ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html
- American Association for Laboratory Accreditation (A2LA). Accredited laboratory directory. https://a2la.org/directory-search/
- International Council for Harmonisation. (2022). ICH guideline Q3A(R2): Impurities in new drug substances. https://www.ich.org/page/quality-guidelines
- European Pharmacopoeia. (2023). Monograph 2.2.29: Liquid chromatography. Ph. Eur. 11.0. https://doi.org/10.1007/978-3-211-89836-9_515
- González-López, N. M., Guerra-Acero-Turizo, L. M., Blanco-Medina, I., et al. (2023). In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides. Biomedical Chromatography, 37(12), e5741. https://doi.org/10.1002/bmc.5741
- Cristea, C. D., Radu, M., Toboc, A., Stan, C., & David, V. (2023). Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples. Analytical Biochemistry, 682, 115336. https://doi.org/10.1016/j.ab.2023.115336
- U.S. Food and Drug Administration. (2013). Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only. FDA Guidance Document. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/distribution-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only